US20020150921A1
(en)
*
|
1996-02-09 |
2002-10-17 |
Francis Barany |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
CA2395593C
(en)
|
1999-12-24 |
2011-08-02 |
Aventis Pharma Limited |
Azaindoles
|
YU54202A
(sh)
*
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
US6897231B2
(en)
*
|
2000-07-31 |
2005-05-24 |
Signal Pharmaceuticals, Inc. |
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
|
US20050009876A1
(en)
*
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
US7211594B2
(en)
|
2000-07-31 |
2007-05-01 |
Signal Pharmaceuticals, Llc |
Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
|
WO2002016348A1
(en)
*
|
2000-08-09 |
2002-02-28 |
Astrazeneca Ab |
Antiangiogenic bicyclic derivatives
|
IL154618A0
(en)
|
2000-09-11 |
2003-09-17 |
Chiron Corp |
Quinolinone derivatives
|
DE10046029A1
(de)
|
2000-09-18 |
2002-03-28 |
Bayer Ag |
Indazole
|
DE60234510D1
(de)
|
2001-04-16 |
2010-01-07 |
Eisai R&D Man Co Ltd |
1h-indazolverbindungen die jnk hemmen
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
WO2003004488A1
(en)
*
|
2001-07-03 |
2003-01-16 |
Chiron Corporation |
Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
|
US7642278B2
(en)
|
2001-07-03 |
2010-01-05 |
Novartis Vaccines And Diagnostics, Inc. |
Indazole benzimidazole compounds
|
FR2827861B1
(fr)
*
|
2001-07-27 |
2004-04-02 |
Aventis Pharma Sa |
Derives des indazoles ou des indoles, leur utilisation en medecine humaine et plus particulierement en cancerologie
|
US20040077702A1
(en)
*
|
2001-09-14 |
2004-04-22 |
Wen-Mei Fu |
Treatment of nuerodegenerative diseases
|
NZ531765A
(en)
*
|
2001-09-26 |
2006-02-24 |
Pharmacia Italia S |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
|
WO2003032984A1
(en)
|
2001-10-19 |
2003-04-24 |
Ortho-Mcneil Pharmaceutical,Inc. |
2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
|
FR2831536A1
(fr)
*
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
US6897208B2
(en)
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
WO2003035065A1
(en)
*
|
2001-10-26 |
2003-05-01 |
Aventis Pharmaceuticals Inc |
Benzimidazoles and analogues and their use as protein kinases inhibitors
|
FR2831537B1
(fr)
*
|
2001-10-26 |
2008-02-29 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation
|
US7074805B2
(en)
*
|
2002-02-20 |
2006-07-11 |
Abbott Laboratories |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
|
US6867320B2
(en)
*
|
2002-02-21 |
2005-03-15 |
Asahi Kasei Pharma Corporation |
Substituted phenylalkanoic acid derivatives and use thereof
|
US7351729B2
(en)
*
|
2002-03-08 |
2008-04-01 |
Signal Pharmaceuticals, Llc |
JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
|
FR2836914B1
(fr)
|
2002-03-11 |
2008-03-14 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
US7166293B2
(en)
*
|
2002-03-29 |
2007-01-23 |
Carlsbad Technology, Inc. |
Angiogenesis inhibitors
|
US20050119278A1
(en)
*
|
2002-05-16 |
2005-06-02 |
Che-Ming Teng |
Anti-angiogenesis methods
|
JP2005528105A
(ja)
*
|
2002-05-30 |
2005-09-22 |
セルジーン・コーポレーション |
細胞分化をモジュレートするため、並びに骨髄増殖性疾患及び骨髄異形成症候群を治療するためのjnk又はmkk阻害剤の使用方法
|
KR20050004214A
(ko)
*
|
2002-05-31 |
2005-01-12 |
에자이 가부시키가이샤 |
피라졸 화합물 및 이것을 포함하여 이루어지는 의약 조성물
|
JP2004075673A
(ja)
*
|
2002-06-19 |
2004-03-11 |
Mitsubishi Chemicals Corp |
化合物およびこれを用いた有機電界発光素子
|
GB0218625D0
(en)
*
|
2002-08-10 |
2002-09-18 |
Astex Technology Ltd |
Pharmaceutical compounds
|
MXPA05001688A
(es)
|
2002-08-12 |
2005-04-19 |
Sugen Inc |
3-pirrolil-piridopirazoles y 3-pirrolil-indazoles como inhibidores de cinasa novedosos.
|
US20040087642A1
(en)
*
|
2002-10-24 |
2004-05-06 |
Zeldis Jerome B. |
Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
|
US20060058366A1
(en)
*
|
2002-12-03 |
2006-03-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Jnk inhibitor
|
PT1585743E
(pt)
*
|
2002-12-19 |
2007-07-12 |
Pfizer |
Compostos de 2- (1h-indazol-6-ilamin)-benzamida como inibidores de proteína-cinases úteis para o tratamento de doenças aftálmicas.
|
US20050019366A1
(en)
*
|
2002-12-31 |
2005-01-27 |
Zeldis Jerome B. |
Drug-coated stents and methods of use therefor
|
US6933311B2
(en)
*
|
2003-02-11 |
2005-08-23 |
Abbott Laboratories |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
|
JP2006518368A
(ja)
*
|
2003-02-21 |
2006-08-10 |
ファイザー・インク |
プロテインキナーゼ阻害剤としてのn−ヘテロシクリル置換アミノチアゾール誘導体
|
ES2214150B1
(es)
*
|
2003-02-27 |
2005-12-01 |
J. URIACH & CIA S.A. |
"nuevos derivados de pirazolopiridinas".
|
DE602004029145D1
(de)
*
|
2003-02-27 |
2010-10-28 |
Palau Pharma Sa |
Pyrazolopyridin-derivate
|
WO2004093873A1
(en)
|
2003-04-17 |
2004-11-04 |
Janssen Pharmaceutica, N.V. |
2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
|
FR2854159B1
(fr)
*
|
2003-04-25 |
2008-01-11 |
Aventis Pharma Sa |
Nouveaux derives de l'indole, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de kdr
|
US7015233B2
(en)
*
|
2003-06-12 |
2006-03-21 |
Abbott Laboratories |
Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
ITRM20030355A1
(it)
*
|
2003-07-18 |
2005-01-19 |
Sigma Tau Ind Farmaceuti |
Composti ad attivita' citotossica derivati della combretastatina.
|
KR101204247B1
(ko)
|
2003-07-22 |
2012-11-22 |
아스텍스 테라퓨틱스 리미티드 |
3,4-이치환된 1h-피라졸 화합물 및 그의 시클린 의존성키나제 (cdk) 및 글리코겐 합성효소 키나제-3(gsk-3) 조정제로서 용도
|
KR20060119705A
(ko)
*
|
2003-07-30 |
2006-11-24 |
교와 핫꼬 고교 가부시끼가이샤 |
인다졸 유도체
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
AU2004260759B2
(en)
*
|
2003-07-30 |
2010-04-22 |
Kyowa Hakko Kirin Co., Ltd. |
Protein kinase inhibitors
|
US20050090529A1
(en)
*
|
2003-07-31 |
2005-04-28 |
Pfizer Inc |
3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
AU2004261667A1
(en)
*
|
2003-08-01 |
2005-02-10 |
Genelabs Technologies, Inc. |
Bicyclic imidazol derivatives against Flaviviridae
|
US20050113576A1
(en)
*
|
2003-08-05 |
2005-05-26 |
Chih-Hung Lee |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
|
WO2005014554A1
(en)
*
|
2003-08-08 |
2005-02-17 |
Astex Therapeutics Limited |
1h-indazole-3-carboxamide compounds as mapkap kinase modulators
|
AU2004265191A1
(en)
|
2003-08-14 |
2005-02-24 |
Asahi Kasei Pharma Corporation |
Substituted arylalkanoic acid derivative and use thereof
|
JP2005089457A
(ja)
|
2003-09-03 |
2005-04-07 |
Yung Shin Pharmaceutical Industry Co Ltd |
骨成長を促進するまたは骨吸収を阻害するための薬剤組成物
|
US6984652B2
(en)
|
2003-09-05 |
2006-01-10 |
Warner-Lambert Company Llc |
Gyrase inhibitors
|
JP4879739B2
(ja)
*
|
2003-09-08 |
2012-02-22 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
チエノピラゾール
|
EP1679308B1
(en)
*
|
2003-10-15 |
2013-07-24 |
Ube Industries, Ltd. |
Novel indazole derivative
|
CA2544591A1
(en)
*
|
2003-11-06 |
2005-05-26 |
Celgene Corporation |
Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders
|
WO2005047244A2
(en)
|
2003-11-07 |
2005-05-26 |
Chiron Corporation |
Inhibition of fgfr3 and treatment of multiple myeloma
|
US20060179711A1
(en)
*
|
2003-11-17 |
2006-08-17 |
Aerogrow International, Inc. |
Devices and methods for growing plants
|
EP1692128A1
(en)
*
|
2003-11-19 |
2006-08-23 |
Signal Pharmaceuticals LLC |
Indazole compounds and methods of use thereof as protein kinase inhibitors
|
US7488817B2
(en)
*
|
2004-02-02 |
2009-02-10 |
The Trustees Of The University Of Pennsylvania |
Metal complex protein kinase inhibitors
|
WO2005094823A1
(ja)
*
|
2004-03-30 |
2005-10-13 |
Kyowa Hakko Kogyo Co., Ltd. |
Flt-3阻害剤
|
BRPI0509580A
(pt)
*
|
2004-03-30 |
2007-11-27 |
Pfizer Prod Inc |
combinações de inibidores de transdução de sinal
|
GB0409080D0
(en)
*
|
2004-04-23 |
2004-05-26 |
Biofocus Discovery Ltd |
Compounds which interact with protein kinases
|
JP2008508218A
(ja)
*
|
2004-07-27 |
2008-03-21 |
ノバルティス アクチエンゲゼルシャフト |
Hsp90阻害剤
|
US20070054916A1
(en)
*
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
FR2876584B1
(fr)
*
|
2004-10-15 |
2007-04-13 |
Centre Nat Rech Scient Cnrse |
Utilisation de la kenpaullone pour la fabrication de medicaments pour le traitement de la mucoviscidose et de maladies liees a un defaut d'adressage des proteines dans les cellules
|
WO2006054143A1
(en)
*
|
2004-11-17 |
2006-05-26 |
Pfizer Inc. |
Polymorphs of {5-[3-(4,6-difluoro-1h-benzoimidazol-2-yl)-1h-indazol-5-yl]-4-methyl-pyridin-3-ylmethyl}-ethyl-amine
|
US20060116519A1
(en)
*
|
2004-11-17 |
2006-06-01 |
Agouron Pharmaceuticals, Inc. |
Synthesis of 5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester
|
MX2007006066A
(es)
*
|
2004-11-23 |
2007-07-11 |
Celgene Corp |
Inhibidores de jnk para el tratamiento de lesiones del snc.
|
JP5507049B2
(ja)
|
2004-12-30 |
2014-05-28 |
アステックス、セラピューティックス、リミテッド |
医薬品
|
MX2007008810A
(es)
|
2005-01-21 |
2007-11-21 |
Astex Therapeutics Ltd |
Compuestos farmaceuticos.
|
EP1845973B1
(en)
|
2005-01-21 |
2015-08-12 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
EP1847532B1
(en)
|
2005-01-27 |
2013-06-05 |
Kyowa Hakko Kirin Co., Ltd. |
Igf-1r inhibitor
|
GT200600042A
(es)
|
2005-02-10 |
2006-09-27 |
Aventis Pharma Inc |
Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
|
US20070004777A1
(en)
*
|
2005-03-23 |
2007-01-04 |
Bhagwat Shripad S |
Methods for treating or preventing acute myelogenous leukemia
|
WO2006105262A1
(en)
|
2005-03-29 |
2006-10-05 |
Icos Corporation |
HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl
|
CN101208333A
(zh)
*
|
2005-04-29 |
2008-06-25 |
细胞基因公司 |
1-(5-(1h-1,2,4-三唑-5-基)(1h-吲唑-3-基))-3-(2-哌啶基乙氧基)苯的固体形式
|
EP1888556B1
(en)
|
2005-05-17 |
2011-10-26 |
Novartis AG |
Methods for synthesizing heterocyclic compounds
|
WO2006130673A1
(en)
|
2005-05-31 |
2006-12-07 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
ES2580108T3
(es)
|
2005-07-11 |
2016-08-19 |
Aerie Pharmaceuticals, Inc |
Compuestos de isoquinolina
|
WO2007058626A1
(en)
*
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Indazole compounds
|
JP2009517481A
(ja)
|
2005-11-29 |
2009-04-30 |
ノバルティス アクチエンゲゼルシャフト |
キノリノンの製剤
|
JP2009523845A
(ja)
*
|
2006-01-23 |
2009-06-25 |
クリスタルゲノミクス インコーポレーテッド |
たんぱく質キナーゼの活性を阻害するイミダゾピリジン誘導体、これの製造方法およびこれを含む薬学組成物
|
AU2007213452A1
(en)
*
|
2006-02-10 |
2007-08-16 |
Biomarin Iga Limited |
Treatment of Duchenne muscular dystrophy
|
BRPI0709082A2
(pt)
*
|
2006-03-23 |
2011-06-28 |
Hoffmann La Roche |
derivados de indazol substituìdos, sua fabricação e uso como agentes farmacêuticos
|
EP2036893A4
(en)
|
2006-06-30 |
2011-04-13 |
Kyowa Hakko Kirin Co Ltd |
ABL Kinase Inhibitor
|
CN101484426A
(zh)
*
|
2006-06-30 |
2009-07-15 |
协和发酵麒麟株式会社 |
Aurora抑制剂
|
JPWO2008020606A1
(ja)
*
|
2006-08-16 |
2010-01-07 |
協和発酵キリン株式会社 |
血管新生阻害剤
|
WO2008024945A1
(en)
*
|
2006-08-25 |
2008-02-28 |
Abbott Laboratories |
Indazole derivatives that inhibit trpv1 and uses thereof
|
CL2007002617A1
(es)
|
2006-09-11 |
2008-05-16 |
Sanofi Aventis |
Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
|
CA2664335C
(en)
|
2006-09-20 |
2014-12-02 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
EP2073807A1
(en)
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
US8916552B2
(en)
|
2006-10-12 |
2014-12-23 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
US20100022517A1
(en)
*
|
2006-12-18 |
2010-01-28 |
Richards Lori A |
Ophthalmic formulation of rho kinase inhibitor compound
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
US8030504B2
(en)
*
|
2006-12-20 |
2011-10-04 |
Abbott Laboratories |
Antagonists of the TRPV1 receptor and uses thereof
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
US8063089B2
(en)
*
|
2007-02-28 |
2011-11-22 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibitors of nucleophosmin (NPM) and methods for inducing apoptosis
|
US20100104567A1
(en)
|
2007-03-05 |
2010-04-29 |
Kyowa Hakko Kirin Co., Ltd. |
Pharmaceutical composition
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
BRPI0811065A2
(pt)
*
|
2007-06-08 |
2014-12-02 |
Abbott Lab |
Indazóis 5-heteroaril substituídos como inibidores de quinase
|
JP5348725B2
(ja)
*
|
2007-10-25 |
2013-11-20 |
ジェネンテック, インコーポレイテッド |
チエノピリミジン化合物の製造方法
|
US8455514B2
(en)
|
2008-01-17 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-and 7-amino isoquinoline compounds and methods for making and using the same
|
CA2719018A1
(en)
*
|
2008-03-20 |
2009-09-24 |
Abbott Laboratories |
Methods for making central nervous system agents that are trpv1 antagonists
|
CN104710365A
(zh)
|
2008-04-28 |
2015-06-17 |
旭化成制药株式会社 |
苯丙酸衍生物及其用途
|
US8106039B2
(en)
*
|
2008-04-30 |
2012-01-31 |
The Trustees Of The University Of Pennsylvania |
Metal complex phosphatidyl-inositol-3-kinase inhibitors
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
JP5629752B2
(ja)
|
2009-04-06 |
2014-11-26 |
ユニバーシティ・ヘルス・ネットワークUniversity Health Network |
キナーゼインヒビターおよびこれを用いた癌の治療方法
|
ES2834451T3
(es)
*
|
2009-05-01 |
2021-06-17 |
Aerie Pharmaceuticals Inc |
Inhibidores de mecanismo doble para el tratamiento de enfermedades
|
WO2011019648A1
(en)
*
|
2009-08-10 |
2011-02-17 |
Epitherix, Llc |
Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof
|
US8252812B2
(en)
*
|
2009-08-10 |
2012-08-28 |
Samumed, Llc |
Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof
|
TWI531571B
(zh)
|
2009-11-06 |
2016-05-01 |
維它藥物公司 |
六氫茚并吡啶及八氫苯并喹啉之芳基-及雜芳基羰基衍生物
|
JP5822844B2
(ja)
|
2009-12-21 |
2015-11-24 |
サミュメッド リミテッド ライアビリティ カンパニー |
1H−ピラゾロ[3,4−b]ピリジンおよびその治療的使用
|
JP5442906B2
(ja)
|
2010-04-06 |
2014-03-19 |
ユニバーシティ・ヘルス・ネットワーク |
キナーゼインヒビターおよびこれを用いた癌の治療方法
|
WO2012020725A1
(ja)
*
|
2010-08-10 |
2012-02-16 |
塩野義製薬株式会社 |
Npy y5受容体拮抗作用を有するヘテロ環誘導体
|
JP6086864B2
(ja)
|
2010-08-18 |
2017-03-01 |
サミュメッド リミテッド ライアビリティ カンパニー |
カテニンシグナル伝達経路活性化剤としてのジケトンおよびヒドロキシケトン
|
TWI537258B
(zh)
|
2010-11-05 |
2016-06-11 |
百靈佳殷格翰國際股份有限公司 |
六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
|
JP2014500277A
(ja)
|
2010-12-09 |
2014-01-09 |
アムジエン・インコーポレーテツド |
Pim阻害剤としての二環式化合物
|
US9321756B2
(en)
|
2011-03-22 |
2016-04-26 |
Amgen Inc. |
Azole compounds as PIM inhibitors
|
EP2694060A4
(en)
*
|
2011-04-01 |
2014-09-10 |
Univ Utah Res Found |
SUBSTITUTED 3- (1H-BENZO [D] IMIDAZOL-2-YL) -1H-INDAZOLE ANALOGUES AS INHIBITORS OF PDK1 KINASE
|
HUE041576T2
(hu)
|
2011-09-14 |
2019-05-28 |
Samumed Llc |
Indazol-3-karboxamid-származékok és alkalmazásuk Wnt/b-katenin szignalizáló útvonal inhibitorokként
|
WO2013063321A1
(en)
|
2011-10-25 |
2013-05-02 |
The General Hospital Corporation |
Wnt/b-catenin inhibitors and methods of use
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
LT2770994T
(lt)
|
2012-05-04 |
2019-12-10 |
Samumed Llc |
1h-pirazolo[3,4-b]piridinai ir jų terapiniai panaudojimai
|
WO2014041518A1
(en)
*
|
2012-09-14 |
2014-03-20 |
Glenmark Pharmaceuticals S.A. |
Thienopyrrole derivatives as itk inhibitors
|
US9908867B2
(en)
|
2013-01-08 |
2018-03-06 |
Samumed, Llc |
3-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof
|
CN104370889A
(zh)
*
|
2013-01-24 |
2015-02-25 |
韩冰 |
一类降低眼压的化合物及其制备方法和用途
|
PL2968249T3
(pl)
|
2013-02-22 |
2019-06-28 |
Samumed, Llc |
Gamma-diketony jako aktywatory szlaku sygnałowego Wnt/beta-kateniny
|
WO2014134774A1
(en)
|
2013-03-04 |
2014-09-12 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
WO2014137728A1
(en)
|
2013-03-04 |
2014-09-12 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
WO2014134776A1
(en)
|
2013-03-04 |
2014-09-12 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
WO2014134772A1
(en)
*
|
2013-03-04 |
2014-09-12 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
PT3811943T
(pt)
|
2013-03-15 |
2023-03-15 |
Aerie Pharmaceuticals Inc |
Composto para uso no tratamento de distúrbios oculares
|
DK3027605T3
(en)
|
2013-07-31 |
2018-01-22 |
Council Scient Ind Res |
Hitherto UNKNOWN INDAZOL RELATIONS AND PROCEDURES FOR PREPARING IT
|
EP3057593B1
(en)
|
2013-10-18 |
2021-12-08 |
University Health Network |
Treatment for pancreatic cancer
|
CA2954298A1
(en)
|
2014-07-24 |
2016-01-28 |
Beta Pharma, Inc. |
2-h-indazole derivatives as cyclin-dependent kinase (cdk) inhibitors and therapeutic uses thereof
|
PT3206686T
(pt)
|
2014-08-20 |
2020-01-06 |
Samumed Llc |
Gama-dicetonas para o tratamento e prevenção de rugas e do envelhecimento da pele
|
WO2016040182A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
WO2016040188A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
GB201511382D0
(en)
|
2015-06-29 |
2015-08-12 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
WO2017023993A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024015A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017023972A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10285982B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023988A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017023989A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017023996A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
WO2017024021A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
US10226448B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
|
US10463651B2
(en)
|
2015-08-03 |
2019-11-05 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
|
US10231956B2
(en)
|
2015-08-03 |
2019-03-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017024025A1
(en)
|
2015-08-03 |
2017-02-09 |
Sunil Kumar Kc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017023975A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
WO2017024968A1
(zh)
*
|
2015-08-07 |
2017-02-16 |
南京明德新药研发股份有限公司 |
作为fgfr和vegfr抑制剂的乙烯基化合物
|
WO2017079765A1
(en)
|
2015-11-06 |
2017-05-11 |
Samumed, Llc |
Treatment of osteoarthritis
|
US10550087B2
(en)
|
2015-11-17 |
2020-02-04 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
AR108326A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
HUE060797T2
(hu)
|
2016-06-01 |
2023-04-28 |
Biosplice Therapeutics Inc |
Eljárás N-(5-(3-(7-(3-fluorfenil)-3H-imidazo[4,5-c]piridin-2-il)-1H-indazol-5-il)- piridin-3-il)-3-metilbutánamid elõállítására
|
WO2018006795A1
(zh)
*
|
2016-07-05 |
2018-01-11 |
广州再极医药科技有限公司 |
芳香乙炔或芳香乙烯类化合物、其中间体、制备方法、药物组合物及应用
|
US11352328B2
(en)
|
2016-07-12 |
2022-06-07 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus
|
CN109640966A
(zh)
|
2016-08-31 |
2019-04-16 |
爱瑞制药公司 |
眼用组合物
|
AU2017345699A1
(en)
*
|
2016-10-21 |
2019-05-16 |
Samumed, Llc |
Methods of using indazole-3-carboxamides and their use as Wnt/B-catenin signaling pathway inhibitors
|
WO2018085865A1
(en)
|
2016-11-07 |
2018-05-11 |
Samumed, Llc |
Single-dose, ready-to-use injectable formulations
|
AU2018243687C1
(en)
|
2017-03-31 |
2020-12-24 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
US10604514B2
(en)
|
2017-10-19 |
2020-03-31 |
Samumed, Llc |
6-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereof
|
US10653688B2
(en)
|
2017-10-27 |
2020-05-19 |
Samumed, Llc |
6-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereof
|
WO2019084496A1
(en)
|
2017-10-27 |
2019-05-02 |
Samumed, Llc |
6- (HETEROARYL 5-CHAIN) ISOQUINOLIN-3-YL- (HETEROARYL 5-CHAIN) CARBOXAMIDES, PREPARATION AND USE
|
US10703748B2
(en)
|
2017-10-31 |
2020-07-07 |
Samumed, Llc |
Diazanaphthalen-3-yl carboxamides and preparation and use thereof
|
SG11202005962YA
(en)
|
2017-12-29 |
2020-07-29 |
Guangzhou Maxinovel Pharmaceuticals Co Ltd |
Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
|
ES2945558T3
(es)
|
2018-02-23 |
2023-07-04 |
Biosplice Therapeutics Inc |
Indazol-3-carboxamidas sustituidas con 5-heteroarilo y preparación y uso de las mismas
|
WO2019241540A1
(en)
|
2018-06-15 |
2019-12-19 |
Samumed, Llc |
Indazole containing macrocycles and therapeutic uses thereof
|
EP3849555A4
(en)
|
2018-09-14 |
2022-05-04 |
Aerie Pharmaceuticals, Inc. |
ARYL CYCLOPROPYL AMINO ISOCHINOLINYL AMIDE COMPOUNDS
|
WO2020150545A1
(en)
|
2019-01-17 |
2020-07-23 |
Samumed, Llc |
Pyrazole derivatives as modulators of the wnt/b-catenin signaling pathway
|
EP4056558A4
(en)
*
|
2019-11-06 |
2023-12-27 |
Jinan University |
INDAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND ITS APPLICATIONS
|
WO2021125229A1
(ja)
*
|
2019-12-17 |
2021-06-24 |
富士フイルム株式会社 |
インダゾール化合物またはその塩および医薬組成物
|
WO2021121420A1
(zh)
*
|
2019-12-20 |
2021-06-24 |
江苏凯迪恩医药科技有限公司 |
苯并吡唑类化合物及其中间体、制备方法和应用
|
WO2021168341A1
(en)
|
2020-02-21 |
2021-08-26 |
Samumed, Llc |
Solid forms of 1-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-n,n-dimethylmethanamine
|
CN112724134B
(zh)
*
|
2021-01-14 |
2022-04-01 |
复旦大学 |
氮杂吲唑联吡啶衍生物髓细胞增殖抑制剂及其制备方法与在制药中的应用
|
WO2023240138A1
(en)
*
|
2022-06-08 |
2023-12-14 |
Blossomhill Therapeutics, Inc. |
Indazole containing macrocycles and their use
|